ArticleJournal of the renin-angiotensin-aldosterone system : JRAAS

The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients.

Amer Harky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.